Dapagliflozin associated with higher risk of ketoacidosis in T2DM patients

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1900卷 / 1期
关键词：
D O I：
10.1007/s40278-022-12358-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [31] Some sulfonylureas increase risk of MACE in patients with T2DM
    Reactions Weekly, 2022, 1899 (1) : 11 - 11
  • [32] Genetic risk score is associated with T2DM and diabetes complications risks
    Hubacek, Jaroslav A.
    Dlouha, Lucie
    Adamkova, Vera
    Dlouha, Dana
    Pacal, Lukas
    Kankova, Katerina
    Galuska, David
    Lanska, Vera
    Veleba, Jiri
    Pelikanova, Terezie
    GENE, 2023, 849
  • [33] Insulin Secretion and Sensitivity Pattern Is Different in patients With T2DM Only or Patients With T2DM and NAFLD
    Pan, Xiaoyu
    Liu, Qing
    Song, Kexiu
    Chai, Shangyu
    Li, Fei
    Huang, Yueye
    Bhavna, Bhavna
    Jhummon, Navina Priya
    Qu, Shen
    DIABETES, 2013, 62 : A492 - A492
  • [34] Absence of hormone-sensitive lipase associated with risk of T2DM
    Joana Osório
    Nature Reviews Endocrinology, 2014, 10 (8) : 445 - 445
  • [35] Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
    Yan, Xueyu
    Si, Jinglei
    Zhong, Fangjie
    Wu, Yanjun
    Jiang, Qinyang
    Guo, Yafen
    Yang, Xiurong
    Liang, Jing
    Lan, Ganqiu
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) : 236 - 244
  • [36] T2DM/CKD genetic risk scores and the progression of diabetic kidney disease in T2DM subjects
    Galuska, David
    Pacal, Lukas
    Chalasova, Katarina
    Divacka, Petra
    Rehorova, Jitka
    Svojanovsky, Jan
    Hubacek, Jaroslav A.
    Lanska, Vera
    Kankova, Katerina
    GENE, 2024, 927
  • [37] Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
    Xueyu Yan
    Jinglei Si
    Fangjie Zhong
    Yanjun Wu
    Qinyang Jiang
    Yafen Guo
    Xiurong Yang
    Jing Liang
    Ganqiu Lan
    International Journal of Diabetes in Developing Countries, 2022, 42 : 236 - 244
  • [38] The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
    Berezin, Alexander A.
    Fushtey, Ivan M.
    Berezin, Alexander E.
    BIOMEDICINES, 2022, 10 (07)
  • [39] Dapagliflozin Improves Glycemic Control and Reduces Body Weight in Patients With T2DM across the Treatment Continuum
    Salsali, Afshin
    Wei, Li
    Wessman, Catrin
    Hardy, Elise
    Ptaszynska, Agata
    Parikh, Shamik
    DIABETES, 2012, 61 : A593 - A594
  • [40] Dapagliflozin as Monotherapy in Drug-Naive Asian Patients With T2DM Inadequately Controlled on Diet and Exercise
    Ji, Linong
    Ma, Jianhua J.
    Li, Hongmei
    Mansfield, Traci A.
    T'Joen, Caroline L.
    Iqbal, Nayyar
    Ptaszynska, Agata
    List, James F.
    DIABETES, 2013, 62 : A286 - A287
12345